Those findings suggest that the combined test can be clinically utilized as an efficient diagnosis strategies for tuberculous pleurisy in clinics when we measure pleural effusion IL-33, ADA and peripheral blood T-SPOT.TB together. This evidence concerns the gene IL33 and tuberculosis.